FULL INTERVIEW: Ruxandra Teslo says John von Neumann would have been a worse drug developer than a mediocre biologist at Pfizer with the right data. In biology, intelligence was never the bottleneck. @RuxandraTeslo is a writer at @WorksInProgMag & @stripe. She joined @theojaffee and @schisofrenia the day after Anthropic's binder results and Moderna's phase 3, to break down what both actually showed: 00:47 what Claude did and didn't do on 14 of 15 targets 03:04 the harder problem isn't…